Active Ingredient(s): Alogliptin
FDA Approved: * January 25, 2013
Pharm Company: * TAKEDA PHARMS USA
Category: Diabetes

Alogliptin, sold under the brand names Nesina and Vipidia,[1][2]) is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.[3] Alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination wi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Nesina 12.5 mg Oral Tablet
NDC: 64764-125
Takeda Pharmaceuticals America, Inc.
Nesina 25 mg Oral Tablet
NDC: 64764-250
Takeda Pharmaceuticals America, Inc.
Nesina 6.25 mg Oral Tablet
NDC: 64764-625
Takeda Pharmaceuticals America, Inc.

Popular Topics


Is it safe to take Nesina with Glimepirde, pioglitazone,and metformin? ## As long as your doctor has prescribed them all...